Determinants and Consequences of Delayed Nephrology Referral in CKD Patients in Pakistan
Main Article Content
Abstract
Background: Timely nephrology referral is important for the evaluation and management of chronic kidney disease (CKD), yet delayed referral remains common in resource-limited settings. Objective: To identify demographic and clinical factors associated with delayed nephrology referral and examine referral timing in relation to renal and biochemical characteristics and the interval to dialysis initiation. Methods: This cross-sectional study included 179 adults with CKD evaluated at a tertiary nephrology unit in Peshawar, Pakistan, between December 2023 and March 2024. Patients were categorized as early (>6 months before dialysis), late (3–6 months), or ultra-late (<3 months) referrals. Demographic, socioeconomic, clinical, laboratory, and referral data were analyzed using descriptive statistics, group comparisons, and univariate logistic regression. Results: Of 179 patients, 60 (33.5%) were referred to early, 16 (8.9%) late, and 103 (57.5%) ultra-late. Late/ultra-late referral was associated with older age, male sex, rural residence, and impaired ambulation. Compared with early referral, late/ultra-late referral was characterized by higher serum creatinine, blood urea nitrogen, potassium, HbA1c and lower eGFR and sodium (all p<0.001). Male sex (OR 2.63, 95% CI 1.36–5.07) and rural residence (OR 5.54, 95% CI 2.71–11.33) were associated with greater odds of delayed referral. Conclusion: Delayed nephrology referral was common and was associated with demographic disparities, poorer kidney function, and an adverse biochemical profile at specialist assessment
Article Details
Issue
Section
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
References
1. Somaili M, Darraj H, Abusageah F, Hakami F, Hakami KM, Zogel B, et al. Rate of vascular access preparation in hemodialysis patients and associated baseline characteristics in Jazan Region, Saudi Arabia: a multicentre study. Open Med J. 2024;11.
2. Okoro RN, Ummate I, Ohieku JD, Yakubu SI, Adibe MO, Okonta MJ. Kidney disease knowledge and its determinants among patients with chronic kidney disease. J Patient Exp. 2020;7(6):1303-1309.
3. Jurkovitz CT, Elliott D, Li S, Saab G, Bomback AS, Norris KC, et al. Physician utilization, risk-factor control, and CKD progression among participants in the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis. 2012;59(3 Suppl 2).
4. Liu W, Zhou L, Yin W, Wang J, Zuo X. Global, regional, and national burden of chronic kidney disease attributable to high sodium intake from 1990 to 2019. Front Nutr. 2023;10.
5. Alemu H, Hailu W, Adane A. Prevalence of chronic kidney disease and associated factors among patients with diabetes in northwest Ethiopia: a hospital-based cross-sectional study. Curr Ther Res Clin Exp. 2020;92:100578.
6. Hooi LS, Ong LM, Ahmad G, Bavanandan S, Ahmad NA, Naidu BM, et al. A population-based study measuring the prevalence of chronic kidney disease among adults in West Malaysia. Kidney Int. 2013;84(5):1034-1040.
7. Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379(9818):815-822.
8. Anand S, Khanam MA, Saquib J, Saquib N, Ahmed T, Alam DS, et al. High prevalence of chronic kidney disease in a community survey of urban Bangladeshis: a cross-sectional study. Global Health. 2014;10(1):1.
9. Jessani S, Bux R, Jafar TH. Prevalence, determinants, and management of chronic kidney disease in Karachi, Pakistan: a community-based cross-sectional study. BMC Nephrol. 2014;15(1):1.
10. Singh AK, Farag YM, Mittal BV, Subramanian KK, Reddy SRK, Acharya VN, et al. Epidemiology and risk factors of chronic kidney disease in India: results from the SEEK (Screening and Early Evaluation of Kidney Disease) study. BMC Nephrol. 2013;14(1):1.
11. Stanifer JW, Muiru A, Jafar TH, Patel UD. Chronic kidney disease in low- and middle-income countries. Nephrol Dial Transplant. 2016;31(6):868-874.
12. Dhanorkar M, Prasad N, Kushwaha R, Behera M, Bhaduaria D, Yaccha M, et al. Impact of early versus late referral to nephrologists on outcomes of chronic kidney disease patients in Northern India. Int J Nephrol. 2022;2022:4768540.
13. Chu CD, Lamprea-Montealegre JA, Estrella MM. Too many for too few: finding appropriate nephrology referrals for patients with CKD that optimize outcomes. Am J Kidney Dis. 2022;79(3):330-332.
14. Kinchen KS, Sadler J, Fink N, Brookmeyer R, Klag MJ, Levey AS, et al. The timing of specialist evaluation in chronic kidney disease and mortality. Ann Intern Med. 2002;137(6):479-486.
15. Smart NA, Titus TT. Outcomes of early versus late nephrology referral in chronic kidney disease: a systematic review. Am J Med. 2011;124(11):1073-1080.e2.
16. Carney EF. The impact of chronic kidney disease on global health. Nat Rev Nephrol. 2020;16(5):251-252.
17. Parameswaran S, Geda SB, Rathi M, Kohli HS, Gupta KL, Sakhuja V, et al. Referral pattern of patients with end-stage renal disease at a public sector hospital and its impact on outcome. Natl Med J India. 2011;24(4):208-213.
18. Daniel WW. Biostatistics: A Foundation for Analysis in the Health Sciences. New York: Wiley; 1978.
19. Lee J, Lee JP, An JN, Kim SG, Kim YL, Yang CW, et al. Factors affecting the referral time to nephrologists in patients with chronic kidney disease: a prospective cohort study in Korea. Medicine (Baltimore). 2016;95(19).
20. Nakamura S, Nakata H, Yoshihara F, Kamide K, Horio T, Nakahama H, et al. Effect of early nephrology referral on the initiation of hemodialysis and survival in patients with chronic kidney disease and cardiovascular diseases. Circ J. 2007;71(4):511-516.
21. Wauters JP, Bosson JL, Forneris G, Turc-Baron C, Golshayan D, Paternoster G, et al. Patient referral is influenced by dialysis centre structure in the Diamant Alpin Dialysis cohort study. Nephrol Dial Transplant. 2004;19(9):2341-2346.
22. Kessler M, Frimat L, Panescu V, Briançon S. Impact of nephrology referral on early and midterm outcomes in ESRD: EPidemiologie de l'Insuffisance REnale chronique terminale en Lorraine (EPIREL): results of a 2-year, prospective, community-based study. Am J Kidney Dis. 2003;42(3):474-485.
23. Tseng CL, Kern EF, Miller DR, Tiwari A, Maney M, Rajan M, et al. Survival benefit of nephrologic care in patients with diabetes mellitus and chronic kidney disease. Arch Intern Med. 2008;168(1):55-62.
24. Smart NA, Dieberg G, Ladhani M, Titus T. Early referral to specialist nephrology services for preventing the progression to end-stage kidney disease. Cochrane Database Syst Rev. 2014;(6).
25. Yun D, Bae S, Park S, Kim YC, Kim DK, Oh KH, et al. Referral to nephrologists is associated with the slow progression of kidney dysfunction in patients with type 2 diabetes mellitus. Kidney Res Clin Pract. 2025.
26. Navaneethan SD, Nigwekar S, Sengodan M, Anand E, Kadam S, Jeevanantham V, et al. Referral to nephrologists for chronic kidney disease care: is non-diabetic kidney disease ignored? Nephron Clin Pract. 2007;106(3).
27. Kazmi WH, Obrador GT, Khan SS, Pereira BJ, Kausz AT. Late nephrology referral and mortality among patients with end-stage renal disease: a propensity score analysis. Nephrol Dial Transplant. 2004;19(7):1808-1814.
28. Stack AG. Impact of timing of nephrology referral and pre-ESRD care on mortality risk among new ESRD patients in the United States. Am J Kidney Dis. 2003;41(2):310-318.
29. Agrawal V, Ghosh AK, Barnes MA, McCullough PA. Perception of indications for nephrology referral among internal medicine residents: a national online survey. Clin J Am Soc Nephrol. 2009;4(2):323-328.
30. Nandita SK, Jagadeesha M, Sanjeev VN, Pramod Kumar M. Understanding factors affecting referral of chronic kidney disease patients: perception of specialist, general physicians and patients. Int J Health Sci. 2022;6(S1):8283-8297.
31. Cheng L, Hu N, Song D, Liu L, Chen Y. Early versus late nephrology referral and patient outcomes in chronic kidney disease: an updated systematic review and meta-analysis. BMC Nephrol. 2025;26(1):25.
32. Spencer D. Health care costs associated with unrecognized progression to late-stage kidney disease. Am J Manag Care. 2023.